Christian Science Monitor: Pulling punchlines: Comedy can be offensive.
UC faculty member Omotayo Banjo speaks to Chappelle controversy
Omotayo Banjo is an associate professor in UC's School of Communication, Film and Media Studies.
Associate professor of communications Omotayo Banjo’s research focuses on representation and audience responses to racial and cultural media; an especially timely topic given the response to Dave Chappelle’s Netflix special “The Closer”.
Thus, Banjo is featured as an expert a Christian Science Monitor article that asks: Is it safe to laugh anymore?
“Comedians are sort of battling with what they can say, what they can get away with,” says Banjo, who wrote her doctoral dissertation on Mr. Chappelle and how audiences react to racial humor.
The article includes a history of comedy and the comics who have pushed boundaries.
Feature photo at top courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
UC’s Ground Floor Makerspace births combat robots
April 17, 2024
In the heart of UC's 1819 Innovation Hub lies the Ground Floor Makerspace, an advanced and active hub of ingenuity where students, faculty and the community converge to bring their ideas to life. This includes being the birthplace of robots much like miniature race cars, combating fender to fender in an enclosed boxing ring. Combat robots like UC's Maximizer will again be fighting for first place in the National Havoc Robot League (NHRL) competition, slated for April 20.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.